Baillie Gifford & Co
Source: SEC Form 13F · as of Mar 2026Baillie Gifford & Co holds 10 biotech & pharma companies tracked by BioSniper, totaling $2.22B in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$2.22B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Moderna, Inc. (MRNA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MRNAModerna, Inc. | 19,985,876 | $1.02B |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,493,866 | $825.1M |
| DNLIDenali Therapeutics Inc. | 12,066,479 | $231.7M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 23,675,407 | $72.7M |
| SANASana Biotechnology, Inc. | 6,609,065 | $19.0M |
| STOKStoke Therapeutics, Inc. | 575,182 | $18.7M |
| RVMDREVOLUTION MEDICINES, INC. | 187,072 | $18.2M |
| DNAGinkgo Bioworks Holdings Inc. | 2,391,649 | $14.7M |
| BEAMBeam Therapeutics Inc. | 385,891 | $9.2M |
| ONCBeOne Medicines Ltd. | 5 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.